Related Experiment Videos
Are changes in end-of-life cancer care coming? IOM, ASCO tackle issues
Journal of the National Cancer Institute
|July 16, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.
Internal medicine journal·2016
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Internal medicine journal·2014
Early palliative care for African American and rural-dwelling advanced cancer family caregivers: long-term outcomes.
Journal of the National Cancer Institute·2026
Critical appraisal of combination therapies: the impact of trial design on Benefit-Risk outcomes.
Journal of the National Cancer Institute·2026
Alcohol consumption and colorectal cancer risk in prediabetes and diabetes: a nationwide cohort study.
Journal of the National Cancer Institute·2026
Physical activity and molecular residual disease in stage III colon cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80702.
Journal of the National Cancer Institute·2026
Temporal trends in relative survival and excess mortality among US adults with lymphoid malignancies.
Journal of the National Cancer Institute·2026
Temporal treatment trends for ductal carcinoma In situ by race and ethnicity in the United States.
Journal of the National Cancer Institute·2026
A Rat Excisional Wound Model for Investigating Therapeutics in Critical-Size Skin Wounds.
Journal of visualized experiments : JoVE·2026
Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review.
Endocrine oncology (Bristol, England)·2026
Combination of Palladium Nanoparticles and Tubastatin-A Potentiates Apoptosis in Human Breast Cancer Cells: A Novel Therapeutic Approach for Cancer [Retraction].
International journal of nanomedicine·2026